Case of epididymitis leading to diagnosis of incomplete behcet's disease
Abstract
A 50-year-old male was diagnosed with acute epididymitis and treated with levofloxacin, however, no improvement was noted. The patient was thus referred to our department for further examinations and treatment. While there were no results indicating pyuria, ceftriaxone was started for acute epididymitis based on clinical findings, though the condition did not improve. Epididymal abscess was suspected, and CT and MRI examinations were performed, which only revealed swelling of the epididymis. The patient was then referred to the Department of Rheumatology for a fever of unknown origin and tested for various autoantibodies, all of which were negative, though gallium scintigraphy showed accumulation in multiple joints. Behcet's disease was suspected and colchicine treatment started, which resulted in a dramatic relief of symptoms. Subsequently, fundus angiography revealed fern-like fluorescent leakage. Furthermore, painful ulcers were found in the oral cavity, leading to a final diagnosis of incomplete Behcet's disease. Presently, colchicine treatment is continuing and there has been no recurrence.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.